Always verify your specific medication type and dosage frequency with your clinical team before making any changes to your routine
GLP-1 Compounding Controversy: What Med Spa Owners Need to Know Key Takeaways The regulatory environment for compounded weight loss medications remains fluid, with FDA decisions creating uncertainty for med spa owners and their patients
However, competition is emerging in the form of danuglipron, a GLP-1 pill from Pfizer
adults have taken GLP-1 medications as of 2024, with about 6% currently using them
As of December 12, the agency is evaluating the need for regulatory action. The appearance of a drug on this list does not mean that FDA has concluded that the drug has the listed risk, the FAERS website says, as noted by CNN
Common manifestations of iron deficiency include fatigue, malaise, and lethargy, which reflect a generalised impairment of energy metabolism [68]